跳至主要内容
临床试验/NCT05232565
NCT05232565已完成不适用

Prospective Multicenter Study to Characterize the REAL-WORLD EVIDENCE Regarding Safety and Performance of the PTCA Catheters Family

Arthesys1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2022年7月29日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Arthesys
入组人数
60
试验地点
1
主要终点
Efficacy endpoint

研究概览

简要总结

The purpose of this Post market Study is to collect clinical data of the Arthesys PTCA catheters family during angioplasty intervention of coronary vessels or coronary bypass graft stenosis to support MDR submission.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient with a Percutaneous intervention to a native coronary or coronary bypass graft indication
  • Patient >18 years
  • Patient who understands the trial requirements and the treatment procedures and provides written informed consent

排除标准

  • Patients will not be included if they are under judicial protection, guardianship or curatorship or if they are deprived of their liberty by judicial or administrative decision.

结局指标

主要结局

Efficacy endpoint

时间窗: Up to end of PTCA procedure

Balloon successfully reaching and crossing target location, successful inflation, deflation, and retrieval in the guiding catheter

Safety endpoint

时间窗: Up to end of PTCA procedure

Successful balloon dilatation without device related adverse event during the dilatation procedure

次要结局

  • Performance - pre-dilatation(Up to end of PTCA procedure)
  • Performance - post-dilatation(Up to end of PTCA procedure)

研究者

发起方
Arthesys
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验